Prof. Yanhua Liang, Shenzhen Hospital of Southern Medical University, China
Dr. Yan-Hua Liang, is a distinguished dermatologist, academic, and researcher. He serves as Chairman and Chief Physician in the Department of Dermatology at Shenzhen Hospital, Southern Medical University. With over two decades of clinical and research experience, he is widely recognized for his contributions to dermatological science and translational medicine. Dr. Liang holds dual PhDs and has trained internationally, including a postdoctoral fellowship at The Jackson Laboratory in the U.S. His commitment to advancing psoriasis therapy, dermatological immunology, and healthcare system improvements is evident in his prolific publication record and mentorship roles. He actively collaborates with global experts and consistently publishes in high-impact journals. Through a career grounded in clinical excellence and research innovation, Dr. Liang continues to shape the field of dermatology in China and beyond.\
Publication Profile:
Scopus
Strengths for the Award
-
Proven Academic Excellence
-
Holds M.D., dual Ph.D.s, and completed a prestigious postdoctoral fellowship at The Jackson Laboratory, USA — reflecting strong scientific and international credentials.
-
Clinical Leadership & Longstanding Experience
-
Research Output & Innovation
-
10+ high-quality peer-reviewed publications (2023–2025) in leading journals like Scientific Reports, Drug Safety, Frontiers in Medicine, and Dermatology.
-
Focus on real-world studies, biologic therapies, psoriasis, autoimmune skin diseases, and translational dermatology — addressing clinically relevant problems.
-
Mentorship and Academic Contributions
-
Active Ph.D. supervisor, guiding the next generation of dermatological researchers.
-
Collaborates with both domestic and international institutions, boosting China’s contribution to global dermatology research.
-
Multidisciplinary Impact & Public Health Relevance
Areas for Improvement
-
International Visibility & Awards
-
While the academic record is strong, international keynote roles, global society leadership, or major global awards are not yet highlighted. These would further elevate his candidacy.
-
Broader Interdisciplinary Integration
-
Could explore collaborative work in AI-driven dermatology, digital diagnostics, or bioinformatics, which are emerging fields in skin science.
Education (150 words)
Dr. Liang’s academic journey reflects a steadfast pursuit of medical excellence. He earned his Bachelor of Medicine from Gannan Medical University (1996–2001), followed by a Master of Science and Ph.D. in Dermatology from Anhui Medical University (2001–2007). To further enrich his scientific acumen, he completed a Postdoctoral Fellowship at The Jackson Laboratory, USA (2007–2010), a premier institution for biomedical research. His education combines strong clinical training with rigorous research methodology, particularly in genetics and dermatological sciences. Dr. Liang’s dual PhDs signify his interdisciplinary focus and commitment to integrating basic science into clinical innovation. His international training has enabled him to bridge Eastern and Western medical practices and adopt a global perspective in addressing skin diseases. With a strong foundation in immunodermatology, translational medicine, and evidence-based treatments, Dr. Liang’s academic background is a cornerstone of his success as a clinician-scientist and mentor.
Experience (150 words)
Dr. Yan-Hua Liang has over 20 years of experience in clinical dermatology and academic leadership. He currently holds the title of Chairman and Professor at the Department of Dermatology, Shenzhen Hospital, Southern Medical University (since 2016). Prior to this, he was a Professor at Nanfang Hospital, also part of Southern Medical University (2012–2015). His clinical expertise spans psoriasis, atopic dermatitis, and autoimmune skin diseases, with a focus on biologic therapies and translational dermatology. He has treated thousands of patients and led major clinical trials in China. As a Ph.D. supervisor, Dr. Liang has mentored numerous postgraduate students and emerging researchers. His leadership has helped modernize dermatological practices, elevate research standards, and foster international collaborations. Recognized for his medical innovations and deep patient care, Dr. Liang stands out as a thought leader in dermatology in the Greater Bay Area and nationally.
Research Focus (150 words)
Dr. Liang’s primary research interests lie in psoriasis treatment, immunodermatology, and translational skin research. He is a pioneer in real-world data analysis of biologic therapies for psoriasis, as demonstrated in several of his prospective, multicenter studies. His focus also includes the gut-skin axis, autoimmune dermatoses, and health policy studies aimed at improving access to dermatological care. In recent years, he has expanded his work into emerging infectious diseases like monkeypox, integrating public health into clinical dermatology. His work is often collaborative, involving multi-disciplinary teams and cross-border research. Dr. Liang is especially committed to improving healthcare delivery systems in dermatology, with a unique emphasis on evidence-based treatment, quality of life metrics, and healthcare worker training. His future focus aims to further explore microbiome-immune interactions in skin disease and introduce AI-driven diagnostic support systems. His research portfolio aligns with global dermatological priorities, positioning him as a leader in innovation and care.
Publications – One-line Format with Emojis
-
Cutaneous and systemic improvements in psoriasis after biologics in real-world study – Scientific Reports, 2025
-
Gut microbiota and psoriasis: A systematic review – Eur J Pharmacol, 2025
-
Hereditary Angioedema in China: Awareness and Advocacy from Greater Bay to Global – Clin Exp Allergy, 2025
-
Healthcare workers’ monkeypox knowledge and confidence survey – World J Clin Cases, 2025
-
Reducing recurrence of Condyloma Acuminatum via lesional auto-transplantation – J Cosmetics, Dermatol Sci Appl, 2024
-
Atopic Dermatitis: From Bench to Bedside – Front Med, 2024
-
Ixekizumab safety in Chinese plaque psoriasis patients – 12-week observational study – Drug Saf, 2024
-
Effectiveness of Ixekizumab in special area involvement psoriasis patients – Dermatol Ther (Heidelb), 2024
-
Quality of life and predictors of complete skin clearance in psoriasis – Dermatology, 2023
-
Ixekizumab safety and efficacy in Chinese psoriasis patients – Prospective real-world study – Adv Ther, 2023
Conclusion
Dr. Yan-Hua Liang is a highly accomplished clinician-scientist whose integrated focus on clinical excellence, academic mentorship, and research productivity positions him as a leading candidate for the Best Researcher Award. His commitment to real-world research, particularly in psoriasis and biologic therapy, is both impactful and timely.
Given his sustained contributions, ongoing innovative work, and national academic leadership, Dr. Liang exemplifies the qualities of a modern, translational researcher who is significantly advancing dermatology in China and beyond.